Comparative analysis of transcatheter arterial embolization and Viabahn covered stent placement in the treatment of delayed hemorrhage after hepatobiliary and pancreatic surgery
10.3760/cma.j.cn113884-20240612-00179
- VernacularTitle:经导管动脉栓塞与Viabahn覆膜支架置入治疗肝胆胰外科术后迟发性出血的对比分析
- Author:
Yunsong MA
1
;
Yabo GOU
;
Chao WANG
;
Bin SHEN
;
Qianxin HUANG
;
Jinchang XIAO
;
Hao XU
;
Maoheng ZU
;
Qingqiao ZHANG
Author Information
1. 徐州医科大学附属医院介入放射科，徐州 221006
- Keywords:
Postoperative hemorrhage;
Postoperative hepatobiliary and pancreatic surgery;
Delayed hemorrhage;
Transcatheter arterial embolization;
Covered stent place
- From:
Chinese Journal of Hepatobiliary Surgery
2024;30(9):652-656
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare the efficacy and safety of transcatheter arterial embolization (TAE) and Viabahn covered stent placement (CSP) for the treatment of delayed hemorrhage after hepatobiliary and pancreatic surgery (DH-HPS).Methods:The clinical data of 41 patients with DH-HPS at the Affiliated Hospital of Xuzhou Medical University from January 2019 to June 2023 were retrospectively analyzed. Among these patients, 27 were male and 14 were female, with an average age of (63.1±10.3) years. 22 patients who underwent TAE was in TAE group and 19 who underwent Viabahn CSP was in CSP group. The interventional treatment effect, blood biochemical indexes and complications were compared between the two groups.Results:In the TAE group, the success rate of hemostasis was 90.9% (20/22), and the rebleeding rate was 9.1% (2/22) after interventional treatment. In the CSP group, the success rate of hemostasis was 94.7% (18/19), and the rebleeding rate of was 5.3% (1/19) after interventional treatment. There was no statistically significant difference in the success rate of hemostasis and the rebleeding rate between the two groups (both P>0.05). The rate of liver function exacerbation after the procedure was 100% (20/20) in the TAE group and 58.8% (10/17) in the CSP group, with a statistically significant difference between the two groups ( χ2=9.77, P=0.002). 37 patients were followed up (18.4±1.7) months, and no rebleeding occurred in all patients. Conclusion:TAE and CSP are both effective for DH-HPS, while CSP is superior to TAE in terms of liver function protection.
